Maysaa Abdulla

Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Abdulla, Maysaa; Sundström, Christer; Lindskog, Cecilia; Hollander, Peter

Ingår i Biomolecules, 2023

• DOI för Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
• Ladda ner fulltext (pdf) av Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology

Skaftason, Aron; Qu, Ying; Abdulla, Maysaa; Nordlund, Jessica et al.

Ingår i Genes, Chromosomes and Cancer, s. 27-36, 2022

• DOI för Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
• Ladda ner fulltext (pdf) av Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology

Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Abdulla, Maysaa; Hollander, Peter; Lindskog, Cecilia; Sundström, Christer et al.

Ingår i Acta Oncologica, s. 824-829, 2022

• DOI för Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Abdulla, Maysaa; Alexsson, Andrei; Sundström, Christer; Ladenvall, Claes et al.

Ingår i Acta Oncologica, s. 531-538, 2021

• DOI för PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
• Ladda ner fulltext (pdf) av PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

Abdulla, Maysaa; Hollander, Peter; Pandzic, Tatjana; Mansouri, Larry et al.

Ingår i American Journal of Hematology, s. 57-67, 2020

• DOI för Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Abdulla, Maysaa; Sundström, Christer; Lindskog, Cecilia; Hollander, Peter

Ingår i Biomolecules, 2023

• DOI för Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases
• Ladda ner fulltext (pdf) av Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases

Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology

Skaftason, Aron; Qu, Ying; Abdulla, Maysaa; Nordlund, Jessica et al.

Ingår i Genes, Chromosomes and Cancer, s. 27-36, 2022

• DOI för Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
• Ladda ner fulltext (pdf) av Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology

Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Abdulla, Maysaa; Hollander, Peter; Lindskog, Cecilia; Sundström, Christer et al.

Ingår i Acta Oncologica, s. 824-829, 2022

• DOI för Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Abdulla, Maysaa; Alexsson, Andrei; Sundström, Christer; Ladenvall, Claes et al.

Ingår i Acta Oncologica, s. 531-538, 2021

• DOI för PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
• Ladda ner fulltext (pdf) av PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

Abdulla, Maysaa; Hollander, Peter; Pandzic, Tatjana; Mansouri, Larry et al.

Ingår i American Journal of Hematology, s. 57-67, 2020

• DOI för Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Amini, Rose-Marie; Ljungström, Viktor; Abdulla, Maysaa; Cavelier, Lucia et al.

Ingår i American Journal of Hematology, 2020

• DOI för Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
• Ladda ner fulltext (pdf) av Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Abdulla, Maysaa; Guglielmo, Priscilla; Hollander, Peter; Åström, Gunnar et al.

Ingår i European Journal of Haematology, s. 207-213, 2020

• DOI för Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research

Abdulla, Maysaa; Laszlo, Sofia; Triumf, Johanna; Hedström, Gustaf et al.

Ingår i Acta Oncologica, s. 106-109, 2017

• DOI för Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

Mansouri, Larry; Noerenberg, Daniel; Young, Emma; Mylonas, Elena et al.

Ingår i Blood, s. 2666-2670, 2016

• DOI för Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients

Abdulla, Maysaa; Laszlo, Sofia; Triumf, Johanna; Hedström, Gustaf et al.

Ingår i Acta Oncologica, s. 1126-1131, 2016

• DOI för A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients

Prognostic signficance of tumor cell markers in diffuse large B-cell lymphoma with special emphasis on lymphoma localization

Abdulla, Maysaa

2020

• Ladda ner fulltext (pdf) av Prognostic signficance of tumor cell markers in diffuse large B-cell lymphoma with special emphasis on lymphoma localization